Cargando…

Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies

Chagas disease (CD) is a neglected disease caused by the parasite Trypanosoma cruzi, which affects underdeveloped countries. The current drugs of choice are nifurtimox and benznidazole, but both have severe adverse effects and less effectivity in chronic infections; therefore, the need to discover n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palos, Isidro, Lara-Ramirez, Edgar E., Lopez-Cedillo, Julio Cesar, Garcia-Perez, Carlos, Kashif, Muhammad, Bocanegra-Garcia, Virgilio, Nogueda-Torres, Benjamin, Rivera, Gildardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152615/ https://www.ncbi.nlm.nih.gov/pubmed/28629155 http://dx.doi.org/10.3390/molecules22061015

Ejemplares similares

Structure-Based Virtual Screening and In Vitro Evaluation of New Trypanosoma cruzi Cruzain Inhibitors
por: Herrera-Mayorga, Verónica, et al.
Publicado: (2019)

The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion
por: Doyle, Patricia S., et al.
Publicado: (2011)

Virtual Screening of FDA-Approved Drugs against Triose Phosphate Isomerase from Entamoeba histolytica and Giardia lamblia Identifies Inhibitors of Their Trophozoite Growth Phase
por: Juárez-Saldivar, Alfredo, et al.
Publicado: (2021)

Structure-Based and Molecular Modeling Studies for the Discovery of Cyclic Imides as Reversible Cruzain Inhibitors With Potent Anti-Trypanosoma cruzi Activity
por: Ferreira, Rafael A. A., et al.
Publicado: (2019)

Arthrospira maxima Paradoxical Effect on Trypanosoma cruzi Infection
por: REBOREDA-HERNANDEZ, Oscar A, et al.
Publicado: (2020)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Non-peptidic Cruzain Inhibitors with Trypanocidal Activity Discovered by Virtual Screening and In Vitro Assay
por: Wiggers, Helton J., et al.
Publicado: (2013)

Predictive Global Models of Cruzain Inhibitors with Large Chemical Coverage
por: Rosas-Jimenez, Jose Guadalupe, et al.
Publicado: (2021)

Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi
por: Planer, Joseph D., et al.
Publicado: (2014)

Facile Synthesis of a Series of Non-Symmetric Thioethers Including a Benzothiazole Moiety and Their Use as Efficient In Vitro anti-Trypanosoma cruzi Agents
por: Avila-Sorrosa, Alcives, et al.
Publicado: (2019)

Computational Identification of Uncharacterized Cruzain Binding Sites
por: Durrant, Jacob D., et al.
Publicado: (2010)

Novel Cruzain Inhibitors for the Treatment of Chagas’ Disease
por: Rogers, Kathleen E, et al.
Publicado: (2012)

Convergent QSAR Models for the Prediction of Cruzain Inhibitors
por: Gonçalves, Rafael Bello, et al.
Publicado: (2023)

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors
por: Sangenito, Leandro Stefano, et al.
Publicado: (2022)

Effect of B-NIPOx in Experimental Trypanosoma cruzi Infection in Mice
por: Reséndiz-Mora, Albany, et al.
Publicado: (2022)

Ligand-Based Virtual Screening and Molecular Docking of Benzimidazoles as Potential Inhibitors of Triosephosphate Isomerase Identified New Trypanocidal Agents
por: Vázquez-Jiménez, Lenci K., et al.
Publicado: (2022)

Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors
por: Medeiros, Alex R., et al.
Publicado: (2021)

Computational approaches towards the discovery and optimisation of cruzain inhibitors
por: Santos, Viviane Corrêa, et al.
Publicado: (2022)

New Amino Naphthoquinone Derivatives as Anti-Trypanosoma cruzi Agents Targeting Trypanothione Reductase
por: Espinosa-Bustos, Christian, et al.
Publicado: (2022)

Azospirillum spp. from Plant Growth-Promoting Bacteria to Their Use in Bioremediation
por: Cruz-Hernández, María Antonia, et al.
Publicado: (2022)

Structural New Data for Mitochondrial Peroxiredoxin From Trypanosoma cruzi Show High Similarity With Human Peroxiredoxin 3: Repositioning Thiostrepton as Antichagasic Drug
por: Rivera-Santiago, Lucio, et al.
Publicado: (2022)

In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-N-oxide Derivatives against Trypanosoma cruzi as Trypanothione Reductase Inhibitors
por: González-González, Alonzo, et al.
Publicado: (2022)

Seropositivity for Trypanosoma cruzi in domestic dogs from Sonora, Mexico
por: Arce-Fonseca, Minerva, et al.
Publicado: (2017)

JVG9, a benzimidazole derivative, alters the surface and cytoskeleton of Trypanosoma cruzi bloodstream trypomastigotes
por: Díaz-Chiguer, Dylan L, et al.
Publicado: (2014)

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity
por: Martinez-Peinado, Nieves, et al.
Publicado: (2020)

Virtual Screening of Benzimidazole Derivatives as Potential Triose Phosphate Isomerase Inhibitors with Biological Activity against Leishmania mexicana
por: Vázquez-Jiménez, Lenci K., et al.
Publicado: (2023)

Synthesis and Anti-Trypanosoma cruzi Activity of Diaryldiazepines
por: Menezes, Júlio César L., et al.
Publicado: (2014)

Profiling the Trypanosoma cruzi Phosphoproteome
por: Marchini, Fabricio K., et al.
Publicado: (2011)

Clathrin expression in Trypanosoma cruzi
por: Kalb, Ligia Cristina, et al.
Publicado: (2014)

Endothelial Transmigration by Trypanosoma cruzi
por: Coates, Bria M., et al.
Publicado: (2013)

The N-myristoylome of Trypanosoma cruzi
por: Roberts, Adam J., et al.
Publicado: (2016)

In Silico Analysis of Homologous Heterodimers of Cruzipain-Chagasin from Structural Models Built by Homology
por: Reyes-Espinosa, Francisco, et al.
Publicado: (2019)

Identification of O-Glcnacylated Proteins in Trypanosoma cruzi
por: Torres-Gutiérrez, Elia, et al.
Publicado: (2019)

Bioluminescent imaging of Trypanosoma cruzi infection in Rhodnius prolixus
por: Henriques, Cristina, et al.
Publicado: (2012)

Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors
por: Avelar, Leandro A. A., et al.
Publicado: (2015)

Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With In Vivo Activity and Favorable Pharmacokinetics
por: Pauli, Ivani, et al.
Publicado: (2022)

Consensus Enolase of Trypanosoma Cruzi: Evaluation of Their Immunogenic Properties Using a Bioinformatics Approach
por: Diaz-Hernandez, Alejandro, et al.
Publicado: (2022)

High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery
por: Alonso-Padilla, Julio, et al.
Publicado: (2014)

Geographical Distribution of Trypanosoma cruzi Genotypes in Venezuela
por: Carrasco, Hernán J., et al.
Publicado: (2012)

Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
por: Afzaal, Hasan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k99hchmrr3ogsc3m8qfpc3j0c1